|
Ranks of resistance rates in China, U.S. and Kuwait, 2001(Rank correlations at bottom of table) |
||||
| Bacterium(a) |
Antibiotic(s) |
China |
U.S. |
Kuwait |
|
|
||||
| SAU |
Methicillin |
3 |
2 |
11 |
| SPN |
Erythromycin |
1 |
4 |
4 |
| Cefotaxime |
21 |
5 |
14 |
|
| Enterococcus spp |
Vancomycin |
20 |
7 |
17 |
| ECO |
Ceftazidime |
15 |
17 |
13 |
| Cefotaxime |
8 |
18 |
15 |
|
| Ceftriaxone |
6 |
19 |
16 |
|
| Ciprofloxacin/Ofloxacin |
2 |
13 |
3 |
|
| PAE |
Ceftazidime |
11 |
8 |
2 |
| Ciprofloxacin/Ofloxacin |
5 |
3 |
1 |
|
| KPN |
Ceftazidime |
16 |
9 |
7 |
| Cefotaxime |
12 |
10 |
8 |
|
| Ceftriaxone |
7 |
11 |
9 |
|
| Ciprofloxacin |
9 |
6 |
6 |
|
| Salmonella spp |
Amoxicillin-clavulanate |
13 |
12 |
12 |
| Ceftriaxone |
19 |
20 |
18 |
|
| Ciprofloxacin |
22 |
21 |
10 |
|
| TMP/SMX |
23 |
14 |
19 |
|
| Gentamicin |
14 |
15 |
20 |
|
| Shigella spp |
Amoxicillin-clavulanate |
4 |
16 |
5 |
| Ceftriaxone |
17 |
23 |
21 |
|
| Ciprofloxacin |
18 |
24 |
22 |
|
| TMP/SMX |
24 |
1 |
23 |
|
| Gentamicin |
10 |
22 |
24 |
|
| Correlation Coefficients |
CHN_US: 0.18 |
US_KW: 0.46 |
CHN_KW: 0.60 |
|
Zhang et al. Globalization and Health 2006 2:6 doi:10.1186/1744-8603-2-6 |
||||